"杏輝"親擦樂夢軟膏

Nazione: Taiwan

Lingua: cinese

Fonte: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Principio attivo:

CHLORPHENIRAMINE MALEATE;;DIPHENHYDRAMINE;;BENZOCAINE (ETHYL AMINOBENZOATE);;SULFADIAZINE;;ZINC OXIDE;;PYRIDOXINE HCL;;MENTHOL

Commercializzato da:

杏輝藥品工業股份有限公司 宜蘭縣冬山鄉中山村中山路84、84之4、84之6、84之7號、冬山鄉中山村新寮路95、95之1、100之7、100之13、100之15、100之16、103、136號 (42042734)

Codice ATC:

D04AX

Forma farmaceutica:

軟膏劑

Composizione:

CHLORPHENIRAMINE MALEATE (0400000810) 1MG; DIPHENHYDRAMINE (0400001600) (BASE) 10MG; SULFADIAZINE (0824000700) 20MG; BENZOCAINE (ETHYL AMINOBENZOATE) (8408000200) 20MG; MENTHOL (8408000300) 3MG; PYRIDOXINE HCL (8810600300) 0.5MG; ZINC OXIDE (9200011500) 30MG

Confezione:

鋁管裝;;塑膠瓶裝

Classe:

製 劑

Tipo di ricetta:

醫師藥師藥劑生指示藥品

Prodotto da:

杏輝藥品工業股份有限公司 宜蘭縣冬山鄉中山村中山路84號 TW

Area terapeutica:

Other antipruritics

Indicazioni terapeutiche:

暫時緩解皮膚搔癢、緩解皮膚刺激及尿布疹

Dettagli prodotto:

有效日期: 2024/05/25; 英文品名: NEO SALOMPASTA OINTMENT "SINPHAR"

Data dell'autorizzazione:

1991-01-24

Foglio illustrativo

                                PIC/S GMP
NEO SALOMPASTA
Ointment
gm
Chlorpheniramine Maleate...........................................1mg
Diphenhydramine Base..............................................10mg
Benzocaine (Ethyl Aminobenzoate) ...........................20mg
Sulfadiazine...............................................................20mg
Zinc
Oxide..................................................................30mg
Pyridoxine
HCl..........................................................0.5mg
Menthol........................................................................3mg
Cetyl stearyl alcohol
Propylene glycol
Liquid
petrolatum White petrolatum Span 60
Tween
60
Methyl paraben
Propyl paraben
Menthol
Water purified.
1000
25
033524
8 4
SINPHAR PHARMACEUTICAL CO., LTD.
84, CHUNG SHAN ROAD, CHUNG SHAN VILLAGE, TUNG - SHAN SHINE, I - LAN,
TAIWAN
(0800)015151
website
h t t p
//www.sinphar.com
R
PIC/S GMP
                                
                                Leggi il documento completo